Delivery Order SPE2DE24D0021-SPE2D625F3XZC
- Not listed
- The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1.65K to Fisher Scientific Company L.L.C. for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic supplies. This fixed-price delivery order with economic price adjustment capability is scheduled for completion by October 22, 2025, and will be performed at Fisher Scientific's facility in Pittsburgh, Pennsylvania. The award represents a child contract under a larger vehicle structure, with no small...
- Fisher Scientific Company L.L.C., a major federal supplier of laboratory and medical equipment, was awarded a delivery order valued at $5,500 on September 12, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent immunodiagnostic supplies. This fixed-price delivery order with economic price adjustment provision will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of November 10, 2025. The contract was awarded without a set-aside designation, indicating open competition. The...
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,100 fixed-price delivery order to Fisher Scientific Company L.L.C. for SOFIA 2 Flu + SARS Antigen Fluorescent testing supplies. Issued on September 5, 2025, this child delivery order will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of November 3, 2025. The contract carries no set-aside designation, reflecting Fisher Scientific's competitive standing in federal procurement. This delivery order...
- The U.S. Department of Defense Medical Supply Chain awarded a $1,100 delivery order to Fisher Scientific Company L.L.C. on September 11, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent immunoassay products. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of November 7, 2025, and will be performed at Fisher Scientific's Pittsburgh, Pennsylvania facility. The award utilized no set-aside designation and represents a competitive procurement to...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $2,200 to Fisher Scientific Company L.L.C. on September 10, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. The contract, which is not set-aside and carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 6, 2025, with performance to be completed in Pittsburgh, Pennsylvania. Fisher Scientific, a major supplier of...
- The U.S. Defense Department's Medical Supply Chain awarded a fixed-price delivery order with economic price adjustment to Fisher Scientific Company L.L.C. on July 22, 2025, for the procurement of SOFIA 2 FLU + SARS 25S diagnostic testing supplies. The delivery order, valued at $4,423.36, represents a child contract with an ultimate completion date of September 17, 2025, and will be performed at Fisher Scientific's facility in Pittsburgh, Pennsylvania. This award was made through open competition...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $5.5K for SOFIA 2 Flu + SARS Antigen Fluorescent I testing supplies under a fixed-price contract with economic price adjustment provisions. The award, issued on September 3, 2025, by the Medical Supply Chain, a defense-focused component within the federal government, is scheduled for completion by October 30, 2025, with performance taking place in Pittsburgh, PA. This delivery order represents a child contract,...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,211.68 on August 6, 2025, for the supply of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic testing supplies. The contract is fixed-price with economic price adjustment provisions and carries an ultimate completion date of October 2, 2025. This delivery order represents a child contract with no set-aside designation, awarded through open competition. The place of performance is located in Pittsburgh, Pennsylvania, and...
- Fisher Scientific Company L.L.C., a major scientific supplier registered with the federal government since 2001, received a $2,700 fixed-price delivery order award from the Medical Supply Chain office under the Defense department on May 8, 2025, for SOFIA SARS Antigen FIA Test Kits (25 units per package). The contract, with an ultimate completion date of June 23, 2025, utilizes fixed-price pricing with economic price adjustment provisions and includes no set-aside designation, indicating open...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,200 for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent testing supplies. The award, issued on September 15, 2025, is a fixed-price contract with economic price adjustment provisions, with an ultimate completion date of November 12, 2025. The contract will be performed in Pittsburgh, Pennsylvania, and was funded through the Department of Defense's Medical Supply Chain division. No set-aside designation was...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F3XZCDelivery Order
The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to Fisher Scientific Company L.L.C. on September 19, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic supplies. This fixed-price contract with economic price adjustment carries a ceiling value of $1,100.00 and is scheduled for completion by November 18, 2025. The contract will be performed in Pittsburgh, Pennsylvania, and was awarded through open competition with no set-aside designation. As a child delivery order, this award leverages an existing contract vehicle, likely a broader General Services Administration Multiple Award Schedule agreement under which Fisher Scientific maintains vendor status. Fisher Scientific Company L.L.C., a long-established federal supplier registered in the System for Award Management since 2001, has demonstrated extensive capabilities in providing laboratory supplies, scientific instruments, and specialized testing solutions across multiple federal agencies including the National Institutes of Health and Department of Veterans Affairs. The company's provision of SOFIA 2 diagnostic reagents supports the Defense Department's medical supply requirements, aligning with broader federal initiatives for rapid infectious disease testing and surveillance capabilities related to influenza and SARS-CoV-2 detection.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/19/25 |